Amount Raised
$50 Million
Round Type
Series A
PortlandHealthcareHealth CareDescription
Sparrow Pharmaceuticals, an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess, today announced the closing of a $50 million Series A financing. OrbiMed led the investment round with participation by RiverVest Venture Partners and U.S. Venture Partners (USVP). This financing will allow the company to accelerate the development of its proprietary oral HSD-1 inhibitor, SPI-62, which targets the source of steroids that cause toxicity in key tissues
Quick answer
Sparrow Pharmaceuticals raised $50 Million in a Series A round, dated May 18, 2021. Sparrow Pharmaceuticals is based in Portland, Oregon, United States.
- How much did Sparrow Pharmaceuticals raise?
- Sparrow Pharmaceuticals raised $50 Million in a Series A round on May 18, 2021.
- What does Sparrow Pharmaceuticals do?
- Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such..
- Where is Sparrow Pharmaceuticals based and how big is it?
- Sparrow Pharmaceuticals is based in Portland, Oregon, United States.
- Who are the decision-makers at Sparrow Pharmaceuticals?
- Fundz holds 1 contact at Sparrow Pharmaceuticals, including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as Sparrow Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Huxley Medical, Inc. raised $10M on June 29, 2021.
- Bluejay Diagnostics raised $1M (Seed) on June 29, 2021.
- Circle Pharma raised $36M on June 29, 2021.
- Enlaza Therapeutics raised an undisclosed amount on June 28, 2021.
- Cagent Vascular raised $9.5M on June 25, 2021.
- ADvantage Therapeutics raised $14M on June 24, 2021.
Who to call at Sparrow Pharmaceuticals, and when
A new round usually means Sparrow Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sparrow Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sparrow Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sparrow Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sparrow Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSparrow Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.